Right to FDA-Approved Medicines Act

HR 4525 (119th Congress) is federal legislation introduced in the U.S. House of Representatives on July 17, 2025. Sponsored by Rep. Ross, Deborah K. [D-NC-2]. Current status: Referred to the House Committee on Energy and Commerce. (2025-07-17).